Eagle Pharmaceuticals
EGRX
#9983
Rank
NZ$29.33 M
Marketcap
$2.26
Share price
26.21%
Change (1 day)
-76.78%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : NZ$0.26 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$0.27 B140.28%
2021-12-31NZ$0.11 B21.52%
2020-12-31NZ$93.1 M-16.82%
2019-12-31NZ$0.11 B-3.55%
2018-12-31NZ$0.11 B-9.35%
2017-12-31NZ$0.12 B40.54%
2016-12-31NZ$91.08 M81.95%
2015-12-31NZ$50.06 M
2014-09-30NZ$26.16 M34.79%
2013-09-30NZ$19.41 M-25.16%
2012-09-30NZ$25.93 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$189.15 B 70,990.84%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$101.35 B 37,992.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$101.21 B 37,941.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$58.52 B 21,896.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$149.70 B 56,164.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$112.22 B 42,079.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$132.72 B 49,784.80%๐Ÿ‡บ๐Ÿ‡ธ USA